Home2018-07-27T04:33:28+00:00

Novel cancer therapies targeting key cancer pathways

READ MORE
Prescient Therapeutics PTX

We are a clinical stage oncology company developing novel drugs
that show great promise as potential new therapies to treat a range of cancers.

prescient therapeutics

OUR COMPANY

Prescient Therapeutics’ novel compounds inhibit key tumor survival pathways, inhibiting cancer growth and overcoming resistance to prior therapies.

Digital Brochure

Two Page Fact Sheet

prescient therapeutics

OUR SCIENCE

Our technologies emanate from renowned institutions Yale University and the Moffitt Cancer Center and are backed by a myriad of peer review publications.

prescient therapeutics

LATEST NEWS

03/04/2019Despatch of Entitlement Offer DocumentsPDF
27/03/2019Notice of General Meeting/Proxy FormPDF
27/03/2019Amended Appendix 3B - Rights IssuePDF
25/03/2019Letter to OptionholderPDF
25/03/2019Letter to Ineligible ShareholdersPDF
25/03/2019Letter to Eligible ShareholdersPDF
25/03/2019Appendix 3B - Rights IssuePDF